5541 - 5550 of 6568 Results
Title
Year
-
OPENTitle: Chronic exposure to dopamine agonists affects the integrity of striatal D2 receptors in Parkinson's patientsJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 16Issue #:Start Page: 455End Page: 460Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2017.08.013Best OA location URL: https://doi.org/10.1016/j.nicl.2017.08.013Citation Count: 35
- Effects of Tyrosine on Parkinson's Disease: A Randomized, Double‐Blind, Placebo‐Controlled Trial2014OPENTitle: Effects of Tyrosine on Parkinson's Disease: A Randomized, Double‐Blind, Placebo‐Controlled TrialJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 1Issue #: 4Start Page: 348End Page: 353Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12082Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12082Citation Count: 16
- LRRK2 deficiency impacts ceramide metabolism in brain2016OPENTitle: LRRK2 deficiency impacts ceramide metabolism in brainJournal Name: Biochemical and Biophysical Research CommunicationsPublisher: Elsevier BVVol: 478Issue #: 3Start Page: 1141End Page: 1146Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bbrc.2016.08.082Citation Count: 64
-
OPENTitle: The anti-parkinsonian drug zonisamide reduces neuroinflammation: Role of microglial Nav 1.6Journal Name: Experimental NeurologyPublisher: Elsevier BVVol: 308Issue #:Start Page: 111End Page: 119Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2018.07.005Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7404626Citation Count: 44
-
OPENTitle: Non-Motor Symptoms as Markers of Disease Severity in Parkinson’s Disease: Associations Between Constipation, Depression, REM Sleep Behavior Disorder, and Motor ImpairmentJournal Name: BiomedicinesPublisher: MDPI AGVol: 13Issue #: 11Start Page: 2704End Page: 2704Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biomedicines13112704Best OA location URL: https://www.mdpi.com/2227-9059/13/11/2704/pdf?version=1762184201Citation Count: 0
-
OPENTitle: Autophagy and mitophagy at the synapse and beyond: implications for learning, memory and neurological disordersJournal Name: AutophagyPublisher: Informa UK LimitedVol: 22Issue #: 1Start Page: 10End Page: 52Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/15548627.2025.2581217Best OA location URL: https://doi.org/10.1080/15548627.2025.2581217Citation Count: 6
-
OPENTitle: In Silico Labeling: Predicting Fluorescent Labels in Unlabeled ImagesJournal Name: CellPublisher: Elsevier BVVol: 173Issue #: 3Start Page: 792End Page: 803.e19Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.cell.2018.03.040Best OA location URL: http://www.cell.com/article/S0092867418303647/pdfCitation Count: 679
-
OPENTitle: Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trialJournal Name: eBioMedicinePublisher: Elsevier BVVol: 80Issue #:Start Page: 104021End Page: 104021Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ebiom.2022.104021Best OA location URL: http://www.thelancet.com/article/S2352396422002055/pdfCitation Count: 85
-
OPENTitle: Intermediate Deformable Image Registration Via Windowed Cross-CorrelationJournal Name: 2023 IEEE 20th International Symposium on Biomedical Imaging (ISBI)Publisher: IEEEVol:Issue #:Start Page: 1End Page: 5Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1109/isbi53787.2023.10230715Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10485808/pdf/nihms-1872292.pdfCitation Count: 2
-
OPENTitle: Cerebrospinal fluid ceruloplasmin levels predict cognitive decline and brain atrophy in people with underlying β-amyloid pathologyJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 139Issue #:Start Page: 104810End Page: 104810Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2020.104810Best OA location URL: https://doi.org/10.1016/j.nbd.2020.104810Citation Count: 38